Impact of modern chemotherapy on the survival of women presenting with de novo metastatic breast cancer.

BMC Cancer · 2012 · PMC3526502 · PMID 23020297

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

approached significanceP=0.06so close (0.05 < p ≤ 0.1)

Although receipt of chemotherapy approached significance as a predictor of survival (HR 0.76, 95%CI 0.57-1.02; P=0.06), there was no significant difference in survival among patients who received agents exclusively from Category A as opposed to both Category A and B (P=0.13).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.